Editor's letter

Issue 87 • June 2025

Don’t miss out – sign up to our free industry-leading magazine and newsletters

Follow us on Twitter

Welcome to the latest issue of the Medical Technology magazine 

The field of Intravascular lithotripsy (IVL), a medical procedure that uses ultrasound shockwaves to break down calcified plaque in arteries, particularly those in the coronary arteries or peripheral arteries, is generating increasing levels of interest.

This month's cover feature looks at the clinical promise IVL holds beyond the financial buzz it has generated in recent times.

This issue also features analyst comment on the impact Trump's tariffs are having on the medical device industry, with companies moving to stockpile equipment in certain areas.

Don't miss our two interviews out of Biomed 2025, which recently took place in Tel Aviv, Israel with each featuring insight into how the bioconvergence and neuromodulation markets are continuing to develop globally.

All this and the latest medtech industry news, comment, and analysis from GlobalData.

Ross Law, deputy editor

Go to article: Home | Intravascular lithotripsyGo to article: Editor's letterGo to article: ContentsGo to article: Repsol Company InsightGo to article: Repsol Go to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: AlleimaGo to article: In DepthGo to article: Intravascular lithotripsy: market competition and clinical potentialGo to article: Neuromodulation: rewiring healthcare?Go to article: US tariffs send tremors through Europe’s medtech industryGo to article: The impact of bio-convergence in healthcareGo to article: Tariffs to push healthcare facilities to stock up on medical devicesGo to article: AI-enabled medical devices present unique cybersecurity threatsGo to article: ListingsGo to article: EventsGo to article: Medical Device Network excellence awards 2024 winnersGo to article: Buyer's GuidesGo to article: Next issue